Post-COVID-19 neurocandidiasis

Miranda, MA; Sousa, SC; Montes, VL

http://hdl.handle.net/10400.26/52931

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Miranda-2021-Post-covid--neurocandidiasis.pdf		648.01 KB	Adobe PDF	Download

Send Feedback

Authors

Miranda, MA

Sousa, SC

Montes, VL

Abstract(s)

Associated with a significant morbidity and mortality, neurocandidiasis affects severely immunocompromised patients, especially if recently treated with antibiotics or corticosteroids. We present the case of a 70-year-old man admitted to an intensive care unit due to a Sars-Cov-2 pneumonia, with fever, coma, and multifocal neurological deficits reported 13 days after extubation. After isolation of Candida albicans in both urine and blood cultures and a brain MRI with multiple gadolinium-enhanced ring lesions, a diagnosis of neurocandidiasis was assumed and aggressive antifungal therapy started. During treatment, the patient developed a hospital-acquired pneumonia with fatal outcome.